Amy Judd Lieberman, J.D., serves as Deputy Director, Harm Reduction Legal Project. Before joining the Network, Amy worked briefly in litigation after a fellowship with the National Health Law Program (NHeLP) working on critical issues related to the opioid epidemic and promoting harm reduction practices, specifically in the communities served by Medicaid and Medi-cal.
Amy serves on the board of directors of the Sidewalk Project Los Angeles, a drug user- and sex worker-led syringe services program serving the unhoused community in downtown Los Angeles, in addition to providing pro bono legal consultation to other SSPs through the California Syringe Exchange Program (CASEP) Coalition.
Amy received her B.F.A from New York University and her J.D. from the University of California, Irvine School of Law. She is barred in California and the United States District Court for the Central District of California.
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether North Carolina law permits the distribution and administration of such naloxone.
International Day of Persons with Disabilities is observed annually to promote awareness and support for the rights and wellbeing of people with disabilities. One in four adults in the United States have a disability, and solutions to advance accessibility, inclusion, and equity must account for the diversity of experiences among people with disabilities. To mark the occasion, Network attorneys highlight recent law and policy developments related to health equity, sexual orientation, and gender identity.
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether Washington law permits the distribution and administration of such naloxone.
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether California law permits the distribution and administration of such naloxone.
Like many others, we recently recognized the 20th International Overdose Awareness Day, and we are especially somber, as we know that the past year has seen more people die from preventable overdose than ever before. The Biden administration acknowledged the gravity of this moment by issuing a proclamation declaring Overdose Awareness Week. Over 94,000 families, friends, co-workers, and neighbors in the United States lost someone they loved. Many more folks faced the trauma of experiencing an overdose, reversing an overdose, or witnessing an overdose.
Parents want to ensure the safety of their children whenever they are passengers in their vehicles by using appropriate car seats or booster seats. Every state has laws regarding child safety restraints for young children while riding in a motor vehicle. However, what happens when parents of young children travel? Rideshares, like Uber and Lyft, are an attractive way to get from the airport to a hotel or other destination. Unfortunately, the requirements around using child safety restraints in rideshares vary by state and are often vague.
This resource summarizes the characteristics of naloxone access and Good Samaritan laws in 50 states and the District of Columbia.
In this webinar, presenters will describe the nature of the laws being announced from the judicial bench or proposed in state legislatures, the process by which they are being formulated in every level and branch of government, and the principles that should guide legal developments as we seek to balance the facts, expert opinion, and civic participation, as well as guard against harmful unforeseen consequences.
The Network has joined with public health law partners to produce a new report, COVID-19 Policy Playbook: Legal Recommendations for a Safer, More Equitable Future, examining policy challenges and opportunities in light of the pandemic. In this Q&A, the Network’s Corey Davis and Amy Lieberman discuss some of the key elements in the chapter they co-authored for the report including the positive impact of opioid use disorder (OUD) treatment, recent changes to increase access to that treatment, and recommendations for permanently reducing legislative and regulatory barriers to effective, evidence-based interventions for OUD.
The United States continues to experience an unprecedented level of drug-related harm. While the failure to prevent this harm is most notable in the number of overdose deaths, which are now at their highest level on record, it is evident in other areas as well. Of particular importance from a policy perspective, bloodborne disease infections related to syringe sharing are also on the rise, with recent outbreaks in Kentucky, Massachusetts, and Indiana, among other states. Cases of infective endocarditis, which is caused largely by unsafe injection, are increasing as well.
This paper identifies barriers to OAT access and potential solutions to improve OAT uptake in eight sectors.
In this Q&A, Corey Davis, deputy director of the Network’s Southeastern Region Office and director of the Network’s Harm Reduction Legal Project; and Amy Lieberman, senior attorney, for the Network’s Harm Reduction Legal Project, discuss some of the key elements in the chapter they authored, Access to Care for Individuals with Opioid Use Disorder, for the Report.
